"10.1371_journal.pone.0064283","plos one","2013-05-27T00:00:00Z","Lars Peters; Amanda Mocroft; Vincent Soriano; Jürgen Rockstroh; Andri Rauch; Anders Karlsson; Brygida Knysz; Christian Pradier; Kai Zilmer; Jens D Lundgren; for EuroSIDA in EuroCoord","Copenhagen HIV Programme, University of Copenhagen, Copenhagen, Denmark; Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark; University College Medical School, Royal Free Campus, London, United Kingdom; Hospital Carlos III, Madrid, Spain; University of Bonn, Bonn, Germany; University Clinic of Infectious Diseases, University Hospital Bern and University of Bern, Bern, Switzerland; Venhälsan, Södersjukhuset, Stockholm, Sweden; Department of Infectious Diseases, Wroclaw Medical University, Wroclaw, Poland; CHU Nice Hopital de ĺArchet 1, Nice, France; West-Tallin Central Hospital, Tallinn, Estonia","¶ Membership of the EuroSIDA Study Group is provided in the Acknowledgments","The authors have declared that no competing interests exist. The EuroSIDA study has received unrestricted grants from Bristol-Myers-Squibb, GlaxoSmithKline, Roche, Gilead, Pfizer, Merck, Tibotec and Boehringer-Ingelheim. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","05","Lars Peters","LP",11,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA
